Sexual health

After Treatment — How Not to Get Reinfected

Save

Reinfection is common and preventable. It happens when a treated person goes back to an untreated partner, so the fix is less about your own medicine and more about the people and habits around you — treating partners, waiting until everyone is clear, condoms, retesting, and doxy-PEP where it fits. Here is how each piece works.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Why do STIs come back after treatment?

Getting the same STI again after treatment is usually not a sign the medicine failed — it is re-exposure. The most common path is a partner who was never treated: they still carry the infection, and the first time you have sex again, it passes right back. Clinicians call this the ping-pong effect, and it is why preventing reinfection is mostly about the people you have sex with, not the drug you took 1.

Two features of most STIs make this easy to miss. Many infections cause no symptoms at all — chlamydia in particular is often completely silent — so an untreated partner has no reason to suspect they are carrying anything 2. And curing the infection does nothing to make you immune; there is no lasting protection, so the next exposure can reinfect you just as the first one did 2.

This is good news in one sense: reinfection is largely preventable, and the levers are practical rather than medical. Reinfection is almost always re-exposure to an untreated partner, not a treatment failure.

Treat every partner, not just yourself

The single most important step is making sure every recent sexual partner gets treated — otherwise the infection just cycles back. Guidance points to partners from roughly the last 60 days for chlamydia and gonorrhea, though a clinician tailors that to your situation 1. When a partner is unlikely to go get seen, providers can often send treatment to them without an in-person visit through expedited partner therapy, or EPT 1.

EPT means your clinician gives you medication or a prescription to pass to a partner who could not otherwise get treated quickly. It is not a substitute for that partner seeing someone themselves — a full evaluation is always better — but it closes the loop when the alternative is no treatment at all. Whether EPT is available depends on where you live: it is permitted in the large majority of U.S. states, but the legal status varies by jurisdiction 3. The partner treatment problem is common enough that it has its own page for when a partner will not get treated.

Wait before you have sex again

The point of treating everyone is so that no one is still carrying the infection when sex resumes — which means a pause. In general, that pause lasts until you and every partner have finished treatment and any required wait has passed; jumping back in while one person is still infectious is exactly how reinfection happens. The precise test-of-cure timing differs by infection and by the specific treatment used, and it is covered in detail on its own page 2.

During that window, the safest assumption is that either of you could still pass the infection, even if symptoms are gone. Symptoms clearing is not the same as the infection being cleared, and for some infections a repeat test matters more than how you feel. If anything is unclear about when it is safe again, that is a question for the clinician who treated you rather than a guess — the timing is specific, not general.

Condoms close the reinfection gap

Between treatment and full retesting — and afterward, with new or non-monogamous partners — condoms are the most reliable everyday tool against reinfection. Used consistently and correctly, they are highly effective at preventing HIV and the STIs spread through genital fluids, including gonorrhea and chlamydia 4. That covers the two infections most likely to ping-pong between partners.

Condoms are not a complete shield, and it helps to know the gap. For infections spread by skin-to-skin contact — herpes, syphilis, and HPV — they lower risk but only partially, because they do not cover every area that can transmit 4. That is not a reason to skip them; it is a reason to pair them with the other layers on this page, especially treating partners and retesting. For a stretch right after treatment, consistent condom use buys time while everyone involved gets clear.

Doxy-PEP: an added layer for some people

For people who keep getting bacterial STIs, there is a newer preventive option called doxy-PEP — an antibiotic taken shortly after sex to lower the chance of a new infection taking hold. CDC recommends counseling and offering it specifically to gay and bisexual men and transgender women who have had syphilis, chlamydia, or gonorrhea in the past year, taken within 72 hours after sex 5. It is aimed squarely at the reinfection problem this page is about.

Doxy-PEP is not for everyone, and it is not a replacement for treating partners or using condoms — it is an extra layer that a clinician decides fits based on your history and risk 5. People using it are also tested for STIs every few months, both to catch infections early and to keep an eye on antibiotic resistance 5. If you have had a bacterial STI recently and reinfection keeps happening, it is worth asking a provider whether doxy-PEP makes sense for you.

Get retested — reinfection is often silent

Because so many reinfections cause no symptoms, a repeat test is how you actually know you are clear, not just how you feel 2. Retesting after treatment is standard practice for chlamydia and gonorrhea, and it catches the reinfections that would otherwise go unnoticed and quietly spread again 6. The exact timing depends on the infection; the principle is simply that finishing treatment is not the end of the process.

Routine screening continues to matter too, on the schedule your risk calls for — CDC bases how often to test on population and exposure rather than a one-size interval 6. A test also only detects an infection once enough time has passed since exposure; the sti window periods differ by infection, which is another reason the timing is specific. Self-collected samples make this easier than it used to be, so a repeat test rarely means an awkward exam. The habit to build is boring but effective: treat, wait, retest, and keep partners in the loop, every time.

Common questions

Usually not. Reinfection almost always means re-exposure — most often to a partner who was never treated and passed the infection back — rather than the medicine failing. STIs do not leave you immune, so a new exposure can infect you again just like the first one. If symptoms never fully cleared, though, that is worth telling your clinician, since it can mean something different.

Generally not until you and every recent partner have finished treatment and any required wait has passed. Having sex while one person is still infectious is the main way reinfection happens. The exact wait and whether you need a repeat test depend on the specific infection and treatment, so the precise timing is best confirmed with the clinician who treated you.

Yes. Most STIs, chlamydia especially, often cause no symptoms at all, so a partner can carry and pass an infection while feeling completely fine. Treating you but not them is exactly what sets up the ping-pong cycle. If a partner is unlikely to get seen quickly, expedited partner therapy can sometimes deliver treatment to them without an in-person visit, where it is legal.

Doxy-PEP is an antibiotic taken shortly after sex to reduce the chance of a bacterial STI. CDC recommends it mainly for gay and bisexual men and transgender women who have had syphilis, chlamydia, or gonorrhea in the past year. It is not for everyone and does not replace condoms or partner treatment — a clinician decides whether it fits your history.

It does not mean your body is broken. Repeat infections almost always trace back to an untreated partner or a new exposure, not a personal failing. The fix is in the pattern around you: making sure partners are treated, pausing sex until everyone is clear, using condoms, retesting, and, for some people, doxy-PEP. Reinfection is common and very preventable.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When reinfection needs a closer look

  • Symptoms that never fully cleared or returned soon after finishing treatment — discharge, burning with urination, or genital sores — which can mean the infection persisted rather than came back
  • Lower-abdominal or pelvic pain, pain during sex, or unusual bleeding after a chlamydia or gonorrhea infection, which can signal pelvic inflammatory disease
  • Fever with pelvic pain, which can mean an infection has spread and needs prompt evaluation

Severe pelvic or lower-abdominal pain with fever after an STI can indicate pelvic inflammatory disease and warrants same-day medical care, or an emergency room if the pain is severe.

This page is general education about preventing STI reinfection, not medical advice. Diagnosis, treatment, partner-treatment options, and the timing of any retest depend on your specific infection and situation and should come from a clinician.

References

  1. 1.Centers for Disease Control and Prevention (2021). Expedited Partner Therapy. CDC STI Treatment Guidelines, 2021. linkThat providers should routinely offer expedited partner therapy (EPT) for chlamydia and gonorrhea when a patient's sex partners (from the previous 60 days) are unlikely to seek timely treatment, so partners are treated and the patient is not reinfected.
  2. 2.Centers for Disease Control and Prevention (2024). About Chlamydia. CDC (cdc.gov/chlamydia). linkThat chlamydia is a common, curable bacterial STI that is frequently asymptomatic ('silent'), so an untreated partner may unknowingly carry and pass it, and can cause pelvic inflammatory disease and infertility if untreated.
  3. 3.Centers for Disease Control and Prevention (2024). Legal Status of Expedited Partner Therapy (EPT). CDC (cdc.gov/sti). linkThat EPT is permissible in the large majority of U.S. states plus DC and that its legal status varies by jurisdiction.
  4. 4.Centers for Disease Control and Prevention (2024). Condom Use: An Overview. CDC (cdc.gov/condom-use). linkThat consistent, correct condom use is highly effective at preventing HIV and STIs spread by genital fluids (gonorrhea, chlamydia) but provides only partial protection against STIs spread by skin-to-skin contact (herpes, syphilis, HPV).
  5. 5.Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024). CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. MMWR Recommendations and Reports, Vol. 73, No. 2. doi:10.15585/mmwr.rr7302a1That CDC recommends counseling and offering doxycycline taken within 72 hours after sex to gay and bisexual men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months.
  6. 6.Centers for Disease Control and Prevention (2024). Getting Tested for STIs. CDC (cdc.gov/sti). linkThat CDC bases who should be tested for which STIs and how often on population and exposure, and that self-collection options exist for STI testing.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy